Blueberries Medical Corp

Company Profile

Blueberries Medical Corp had its IPO on under the ticker symbol BBRRF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Blueberries Medical Corp has a staff strength of 0 employees.

Stock update

Shares of Blueberries Medical Corp opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a -12.97% slip from the previous day's closing price.

A total volume of 58,869 shares were traded at the close of the day’s session.

In the last one week, shares of Blueberries Medical Corp have slipped by -19.5%.

Blueberries Medical Corp's Key Ratios

Blueberries Medical Corp has a market cap of $2.44 million, indicating a price to book ratio of 132.0668 and a price to sales ratio of 23.7226.

In the last 12-months Blueberries Medical Corp’s revenue was $279628 with a gross profit of $-17720 and an EBITDA of $-1222685. The EBITDA ratio measures Blueberries Medical Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Blueberries Medical Corp’s operating margin was -516.28% while its return on assets stood at -29.31% with a return of equity of -125.94%.

In Q1, Blueberries Medical Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 131%.

Blueberries Medical Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.01 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Blueberries Medical Corp’s profitability.

Blueberries Medical Corp stock is trading at a EV to sales ratio of 27.1785 and a EV to EBITDA ratio of -0.8619. Its price to sales ratio in the trailing 12-months stood at 23.7226.

Blueberries Medical Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$3.05 million

Total Liabilities

$1.83 million

Operating Cash Flow

$0

Capital Expenditure

$2834

Dividend Payout Ratio

0%

Blueberries Medical Corp ended 2024 with $3.05 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.05 million while shareholder equity stood at $1.08 million.

Blueberries Medical Corp ended 2024 with $0 in deferred long-term liabilities, $1.83 million in other current liabilities, in common stock, $-23319008.00 in retained earnings and $0 in goodwill. Its cash balance stood at $907273.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Blueberries Medical Corp’s total current assets stands at $1.85 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $86263.00 compared to accounts payable of $0 and inventory worth $60872.00.

In 2024, Blueberries Medical Corp's operating cash flow was $0 while its capital expenditure stood at $2834.

Comparatively, Blueberries Medical Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.02

52-Week High

$0.0366

52-Week Low

$0.0092

Analyst Target Price

$

Blueberries Medical Corp stock is currently trading at $0.02 per share. It touched a 52-week high of $0.0366 and a 52-week low of $0.0366. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.02 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6853.3% of the company’s stock are held by insiders while 0% are held by institutions.